In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health Care and the 2008 Election: Revolution, Reform, or Return to Business as Usual?

Executive Summary

As the presidential race heats up, health care executives say they have many reasons to be excited--and nervous. BCG reviews an industry-wide survey on the implications of the candidates' health care proposals for the pharma and device industries.

Related Content

Bending The Cost Curve: Harvard's Cutler Says Rx Can Play A Big Role
FDA and Health Care Reform: An Activist Agenda for the Agency
FDA Puts Dose Selection At Top Of Agenda For End-Of-Phase 2A Meetings
Biosimilars Pathway Seen As Part Of Health Care Reform Debate Next Year
The Players Who Will Shape Health Care Reform in 2009
Preparing for Health Care Reform: Why Big Pharma Thinks it Can Avoid Another "Hillarycare"





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts